
Radiance
GHK-CU
100mg
$63.75$85.00



Front
Radiance
$123.75$165.00
Strength · 80mg
KLOW 80mg blend — GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg co-lyophilized for in-vitro repair and NF-κB pathway research.
Research Notice
For laboratory research use only. Not for human consumption.
The Dossier
KLOW extends the three-peptide GLOW stack with a fourth reference — KPV — pairing GHK-Cu, BPC-157, and TB-500 with the anti-inflammatory alpha-MSH fragment. Like GLOW it appears as a pale-blue lyophilized powder, the tint owed to its copper-tripeptide component.
It is studied for the combined signaling profile of its constituents, offering a consolidated reference for comparative laboratory work.
Research Focus
Mechanism
The four peptides distribute across complementary compartments: GHK-Cu as a copper-delivery vehicle and gene modulator; BPC-157 through VEGFR2-associated angiogenic signaling; TB-500 through actin-sequestration and cytoskeletal remodeling; and KPV as a distinguishing anti-inflammatory layer.
KPV is characterized as entering cells via the PepT1 transporter and blocking nuclear translocation of NF-κB — an axis reported to be active at low concentrations across the single-agent literature.
Storage & Handling
Store the lyophilized blend at −20°C for extended stability. Reconstituted solution is held at 2–8°C and used within one to two weeks; avoid freeze-thaw cycles and protect from light and moisture.
References
✦Every vial ships with third-party HPLC verification; certificates of analysis are available on request.
Continue Exploring